Recipient Clonal Hematopoiesis in Allogeneic Bone Marrow Transplantation for Lymphoid Malignancies

In this retrospective study, allogeneic blood and marrow transplantation (alloBMT) recipients age 60 and older with lymphoid malignancies were included. Among 97 consecutive patients who received alloBMT between 2017 and 2022, cloal hematopoiesis was detected in 60.